Valvuloplasty stands as a pivotal medical intervention dedicated to addressing valvular heart disease, a condition marked by the impairment or constriction of heart valves. In this sophisticated procedure, a specialized catheter, housing a deflated balloon, navigates through the intricate network of blood vessels until it reaches the targeted heart valve in need of correction. With precision and care, the balloon is then inflated, strategically widening the narrowed valve. This meticulous approach facilitates improved blood circulation, mitigating symptoms associated with valvular disorders and promoting overall cardiovascular health. Distinguished by its minimally invasive nature, valvuloplasty presents a compelling alternative to the conventional realm of open-heart surgery. This innovation translates to shorter recovery periods and diminished postoperative discomfort for patients undergoing the procedure. As medical advancements continue to propel the field forward, valvuloplasty emerges as a beacon of hope for individuals grappling with valvular heart disease, offering a less invasive avenue for restoring cardiac function and enhancing the quality of life.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States